MXPA00002318A - Celulas geneticamente disenadas que expresan proteinas morfogeneticas de hueso. - Google Patents

Celulas geneticamente disenadas que expresan proteinas morfogeneticas de hueso.

Info

Publication number
MXPA00002318A
MXPA00002318A MXPA00002318A MXPA00002318A MXPA00002318A MX PA00002318 A MXPA00002318 A MX PA00002318A MX PA00002318 A MXPA00002318 A MX PA00002318A MX PA00002318 A MXPA00002318 A MX PA00002318A MX PA00002318 A MXPA00002318 A MX PA00002318A
Authority
MX
Mexico
Prior art keywords
bone morphogenetic
morphogenetic proteins
genetically engineered
engineered cells
express bone
Prior art date
Application number
MXPA00002318A
Other languages
English (en)
Inventor
Ioannis Moutsatsos
Original Assignee
Genetics Inst Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc filed Critical Genetics Inst Llc
Publication of MXPA00002318A publication Critical patent/MXPA00002318A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion describe metodos para producir lineas celulares que expresan ADN recombinante que codifica para proteinas morfogeneticas de hueso BMP). Las lineas celulares son capaces de ser implantadas con el proposito de mejorar la regeneracion de tejidos a traves de ambos efectos autocrino y paracrico. Las celulas pueden ademas contener ADN que codifica para proteinas de receptor que son capaces de unirse a Bmps o mejorar o regular la actividad de las BMP .
MXPA00002318A 1997-09-05 1998-09-04 Celulas geneticamente disenadas que expresan proteinas morfogeneticas de hueso. MXPA00002318A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5798997P 1997-09-05 1997-09-05
US09/148,234 US20020102728A1 (en) 1997-09-05 1998-09-04 Genetically engineered cells which express bone morphogenetic proteins
PCT/US1998/018603 WO1999011664A1 (en) 1997-09-05 1998-09-04 Genetically engineered cells which express bone morphogenetic proteins

Publications (1)

Publication Number Publication Date
MXPA00002318A true MXPA00002318A (es) 2006-02-22

Family

ID=22013954

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00002318A MXPA00002318A (es) 1997-09-05 1998-09-04 Celulas geneticamente disenadas que expresan proteinas morfogeneticas de hueso.

Country Status (12)

Country Link
US (2) US20020102728A1 (es)
EP (1) EP1007559B1 (es)
JP (1) JP2001514026A (es)
AT (1) ATE314390T1 (es)
AU (1) AU752556B2 (es)
CA (1) CA2301882A1 (es)
DE (1) DE69832989T2 (es)
DK (1) DK1007559T3 (es)
ES (1) ES2255180T3 (es)
MX (1) MXPA00002318A (es)
PT (1) PT1007559E (es)
WO (1) WO1999011664A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039695A1 (en) * 2001-08-10 2003-02-27 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen carrier of therapeutic genetic material, and method
US9034315B2 (en) 1997-10-10 2015-05-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Cell-charged multi-layer collagen membrane
US20050186283A1 (en) 1997-10-10 2005-08-25 Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie Collagen carrier of therapeutic genetic material, and method
US8858981B2 (en) 1997-10-10 2014-10-14 Ed. Geistlich Soehne Fuer Chemistrie Industrie Bone healing material comprising matrix carrying bone-forming cells
JP2003505205A (ja) * 1999-07-28 2003-02-12 リジェネレーション テクノロジーズ インク． 核酸送達ビヒクルとしての軟骨マトリクス又は骨マトリクス
US6939540B1 (en) * 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
WO2003013588A1 (fr) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire
JP4097544B2 (ja) * 2003-02-27 2008-06-11 独立行政法人理化学研究所 人工リンパ節
AU2004255245B2 (en) * 2003-07-09 2009-10-22 Warsaw Orthopedic, Inc. Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
US20050272678A1 (en) * 2004-02-11 2005-12-08 Bodine Peter Van N BMP-6 estrogen responsive element and methods of use thereof
US7531355B2 (en) * 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
US20120263692A1 (en) * 2009-11-16 2012-10-18 Bertone Alicia L Engineered Xenogeneic Cells for Repair of Biological Tissue
AU2016333996B2 (en) 2015-10-05 2020-05-28 Salk Institute For Biological Studies Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
WO1996039431A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Bone morphogenic protein-10

Also Published As

Publication number Publication date
PT1007559E (pt) 2006-05-31
US20110111505A1 (en) 2011-05-12
US20020102728A1 (en) 2002-08-01
EP1007559B1 (en) 2005-12-28
DE69832989D1 (de) 2006-02-02
AU752556B2 (en) 2002-09-19
DK1007559T3 (da) 2006-05-08
EP1007559A1 (en) 2000-06-14
AU9306298A (en) 1999-03-22
ES2255180T3 (es) 2006-06-16
DE69832989T2 (de) 2006-08-24
WO1999011664A1 (en) 1999-03-11
ATE314390T1 (de) 2006-01-15
CA2301882A1 (en) 1999-03-11
JP2001514026A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
MXPA00002318A (es) Celulas geneticamente disenadas que expresan proteinas morfogeneticas de hueso.
IL142905A0 (en) Functional antagonists of hedgehog activity
EP0814827A4 (en) GROWTH FACTOR-B, SPECIFIC FOR VASCULAR ENDOTHEL CELLS
WO1999046366A8 (en) Uses for humane non-autologous mesenchymal stem cells
EP1778842B8 (en) Compositions and methods of use for mgd-csf in disease treatment
RU2001117230A (ru) Пептиды, ингибирующие трансформирующий фактор роста tgf$$$1
EP0956339A4 (en) RECOMBINANT FACTOR OF VASCULAR ENDOTHELIAL CELL GROWTH (VEGF-D)
HK1026229A1 (en) Modified dorsal tissue affecting factor and compositions
HK1038307A1 (en) Thymosin beta 4 promotes wound repair.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO1999035262A3 (en) Apoptosis inducing molecule ii
EP1439226A3 (en) A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity
WO1997026321A3 (en) Recombinant expression of proteins from secretory cell lines
HK1038313A1 (en) Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding
EP0349342A3 (en) Polypeptides with cell-spreading activity
EP0973794A4 (en) NETRINE RECEIVERS
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
DE69734141D1 (de) PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER
WO2002050111A3 (en) Isolated laminin 10
FI971896A0 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
WO2000066732A3 (en) Laminin 8 and methods for its use
HK1002284A1 (en) Novel implant and novel vector for the treatment of acquired diseases
WO2000061774A3 (en) Bone morphogenic proteins
IL130967A0 (en) Freeze-dried composition of bone morphogenetic protein human mp52
EP1007063A4 (en) BONE REGENERATION IN OSTEOPOROSE USING MESENCHYMIC CELLS FROM HUMAN BONE MARK

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: DATALOGIC IP TECH S.R.L.

FG Grant or registration
MM Annulment or lapse due to non-payment of fees